News & Events

News

Dr. Carles Lerín recognized with the 2025 IFF Science Award for his pioneering research in child nutrition and health

Dr. Carles Lerín, head of the Pediatric Metabolic Diseases Research Group at the Sant Joan de Déu Research Institute (IRSJD), has been awarded the 2025 IFF Science Award, a prestigious international recognition in the fields of nutrition, health, and biomedical research.

  1. The IRSJD reaffirms its commitment to its research team by renewing the HR Excellence in Research Award

    L’Insitut de Recerca Sant Joan de Déu (IRSJD) has been reaccredited with the HR Excellence in Research Award granted by the European Commission, after successfully passing an evaluation conducted by independent experts. This distinction recognizes institutions that promote good practices in research talent management and align their policies with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers.

  2. Parc Sanitari Sant Joan de Déu Hosts the First Doctoral Thesis Defense by a Professional of the Institution at the RISE Center Auditorium

    On September 30, 2025, a very special academic event took place at Parc Sanitari Sant Joan de Déu (PSSJD): the first doctoral thesis defense by a professional of the institution, held in the auditorium of the RISE center.

  1. A study led by SJD identifies new therapeutic targets for Ewing sarcoma

    The study identifies the demethylases KDM6A and KDM6B as essential collaborators of the fusion protein EWSR1::FLI1, responsible for the epigenetic reprogramming that drives tumor growth.

  2. A study by Sant Joan de Déu identifies the mechanisms that hinder the effectiveness of treatment for diffuse intrinsic pontine glioma in children

    DIPG is an aggressive brain tumor that mainly affects pediatric patients and has a poor prognosis in all cases. The research team has identified two key proteins secreted by the tumor that suppress the immune system and promote the formation of barriers that hinder treatment.

  3. Genetic risk for psychiatric disorders is related to emotional and behavioral problems in undiagnosed children

    Genetic susceptibility to developing ADHD shows the strongest association with mental problems during childhood and adolescence compared to genetic risk for other psychiatric conditions.

  4. The Josep Carreras Foundation and Sant Joan de Déu Create a Childhood Leukemia Research Program Worth Over 10 Million Euros

    The Josep Carreras Foundation (FJC), the Josep Carreras Leukemia Research Institute (IJC), and the Sant Joan de Déu Research Institute (IRSJD) have agreed to develop a joint research program on childhood leukemia valued at over 10 million euros.

    Jaume Mora, director científic de l'SJD Pediatric Cancer Center de l'Hospital Sant Joan de Déu Barcelona i investigador de l'IRSJD (al centre), amb José Luis Dapena i Susana Rives, referents en leucèmia del centre.

  5. An aggressive childhood cancer case opens new avenues for advanced cell therapies

    A positive response to therapy in a paediatric patient with a renal rhabdoid tumour has enabled researchers to identify immune cells with anti-tumour activity in this rare cancer.

  6. A study led by Sant Joan de Déu shows promising results for a new treatment for childhood cerebral adrenoleukodystrophy

    An international study led by Sant Joan de Déu explores the first oral therapy to slow childhood cerebral adrenoleukodystrophy, a devastating rare disease.